Generate a tailored SOP for Dr. Christopher Seet. Improve your application with a focused, well-structured draft.
Dr. Christopher Seet is an Assistant Professor-in-Residence in the Department of Medicine at the University of California, Los Angeles, specializing in Hematology-Oncology. His research focuses on the study of human T cell development and anti-tumor T cell responses, aiming to enhance cellular engineering approaches for cancer immunotherapy. He is particularly interested in improving T cell responses in acute myeloid leukemia and myelodysplastic syndrome, understanding the development of engineered T cells from induced pluripotent stem cells, and characterizing new receptors and targets for tumor immunotherapy. Dr. Seet has participated in multiple fellowship and award programs, including the NIH/National Cancer Institute K08 Mentored Clinical Scientist Development Award and the NIH/UCLA CTSI KL2 Translational Science Award. He completed his MD at the University of Sydney and a PhD at the University of California, Los Angeles. His clinical interests encompass a range of hematologic malignancies, including acute myeloid leukemia and chronic myelogenous leukemia, as well as cellular therapy and immunotherapy.
Department of Economics admits primarily for the PhD program.